RPG Investment Advisory’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.6M Buy
346,673
+86,053
+33% +$3.7M 1.71% 26
2026
Q1
$9.58M Buy
260,620
+31,355
+14% +$1.49M 1.16% 39
2025
Q4
$11.7M Buy
229,265
+76,691
+50% +$3.92M 1.32% 32
2025
Q3
$8.47M Buy
152,574
+17,662
+13% +$1.03M 1% 41
2025
Q2
$9.31M Sell
134,912
-50,226
-27% -$3.42M 1.16% 37
2025
Q1
$12.9M Buy
185,138
+101,994
+123% +$8.42M 0.92% 47
2024
Q4
$7.15M Buy
83,144
+24,758
+42% +$2.68M 0.96% 46
2024
Q3
$6.95M Buy
+58,386
New +$7.79M 0.99% 47

Other funds holding NVO

RPG Investment Advisory's NVO Position: Q2 2026 in Review

RPG Investment Advisory increased its Novo Nordisk (NVO) stake by 33% in Q2 2026, buying an estimated $3.7M and bringing the position to 346,673 shares worth $16.6M. The position accounts for 1.71% of the portfolio, ranked #26.

RPG Investment Advisory first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • RPG Investment Advisory held 346,673 shares of Novo Nordisk worth $16.6M as of Q2 2026.
  • RPG Investment Advisory bought 86,053 Novo Nordisk shares in Q2 2026, an estimated $3.7M.
  • Novo Nordisk made up 1.71% of RPG Investment Advisory's portfolio in Q2 2026, its #26 holding.
  • RPG Investment Advisory first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on RPG Investment Advisory's 13F filing for Q2 2026, filed 4 Aug 2026.